Manuel Ruiz-Pablos is a biologist from the Complutense University of Madrid and a clinical and biomedical laboratory technician. He currently collaborates with CIMA, University of Navarra, in the search for biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID. His work focuses on the role of genetic predisposition, immune dysregulation and viral infections, particularly Epstein-Barr virus, in the development of post-infectious and autoimmune diseases.
Manuel Ruiz-Pablos is a biologist from the Complutense University of Madrid and a clinical and biomedical laboratory technician. He currently collaborates with CIMA, University of Navarra, in the search for biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID. His work focuses on the role of genetic predisposition, immune dysregulation and viral infections, particularly Epstein-Barr virus, in the development of post-infectious and autoimmune diseases.